Professional Documents
Culture Documents
www.europa.eu
www.ygeia-pronoia.gr
www.europa.eu
www.epanad.gov.gr
www.ygeia-pronoia.gr
www.epanad.gov.gr
www.espa.gr
www.espa.gr
:
(. ...) 2007-2013 (...) .
:
- ., : -, , :
. , , 2015.
:
www.epilegothilasmo.gr
,
, .
,
. , . .
.
, . ,
. , , , .
.
2015
-
, / ,
,
: , , IBCLC
, , MSc , IBCLC
- ,
, , MSc, MRCPCH, IBCLC
, , IBCLC
, , MSc
,
, , MSc
,
, , MSc
,
,
,
, - , MSc, IBCLC
- , -, PhD
: - ., ,
, , IBCLC
, , MSc-, IBCLC
, , IBCLC
, , MSc
,
, , MSc, MRCPCH, IBCLC
, -, MSc, IBCLC
, -, PhD
,
.
, , , , , . , .
6 .
.
, ,
.
, .
, , , ,
, .
, .
, . , /- , , , , .
.
, ,
. , 89%,
41% 21% , 11%
0,9 % .
: , (. ...) 2007-2013
(...) .
, .
, , , , .
, , , , .
-
() UNICEF (United
Nations Childrens Fund)
.
,
.
1979 UNICEF,
. . 1981
.
,
,
. 1989,
UNICEF.
30 1990 , Innocenti (1990).
1991-1992 (-Baby Friendly Hospital Initiative, BFHI),
. , . UNICEF
, ,
. ,
.
2002 UNICEF
(Global Strategy for Infant & Young Feeding), - - ,
. , :
, .
, .
.
1993, .
1995
3/36189/ 9-10-95, 10 UNICEF :
.
, .
,
.
.
.
2009
. : ,
(. ...) 2007-2013
(...)
.
4316/2014
.
1.
2.
3.
4.
5.
6.
1
1.1
. , , .
. ,
, (. )
.
,
4-5 , 2,5 mm. ,
,
,
.
.
(
12 16 ) .
. ,
.
.
32 40 ( ) - .
, .
, ,
.
. ,
,
.
,
.
.
.
. ,
,
feedback -.
.
.
() . 9,5 10,3 ,
(body mass index/
) .
, ,
. .
, . , , , (TSH)
(ACTH). 16 .
,
. (FSH) (LH)
,
. (
)
.
. ,
.
.
. ,
.
11
(13 28 )
.
(29 40 ). .
,
( ,
).
( ).
, 2.
. , , .
.
12
. , ,
. ,
.
.
A
1.
2.
3.
4.
5.
6.
7.
. . : ; 1989.
. - . : . :
; 2013.
Kahle W., Leonhardt H., Platzer W. , II. (: . ). :
; 1985.
Lauwers J, SwisherA. Counseling The Nursing Mother: A Lactation
Consultants Guide. 5th ed. Sudbury MA: Jones and Bartlett Learning;
2011.
Lawrence RA, Lawrence RM. Breastfeeding: A guide for the Medical
Profession. 7th ed. Missouri, USA: Mosby; 2010.
Neville MC. Anatomy and physiology of lactation. Pediatr Clin North
Am. 2001. Feb;48(1):13-34.
Riordan J.Breastfeeding and Human Lactation (3rded).Sudbury MA,
USA: Jones and Bartlett Publishers; 2005.
1.2
2 6
.
: -, -,
- -. -
, Spence .
Spence
12
-
6
1:
Spence.
, :
. 15-20 , .
2040 10100
. , ,
. ,
(milk let down reflex) . ( 2).
,
,
1-2 mm. , .
,
.
75 % .
,
. ,
,
.
Cooper .
.
, , ,
Bell
.
. , ,
5 7 .
5.
.
8
9
10
cc Patrick J. Lynch, 2006
2:
(1. 2. 3. 4.
5. 6. 7.
8. 9. 10. )
. , .
.
. 60 %
30 % . ,
,
, .
, .
.
,
, 1012mm. 10-15 ,
.
3 : , ,
.
1,5-6 , . 3.
,
. .
, .
10-15
, Montgomery, .
,
13
.
() .
3:
1.
14
.
. 2
.
, . ,
,
, .
Spence,
.
, . , 2-6 % .
().
,
.
4: .
( )
1.3
2 % 6 %
, .
. , ,
( 4). |
,
. . .
2,5kg, .
Dancey et al (2008)
1,5kg, (Dafydd H et al, 2011)
3 % .
.
,
.
80 %
, , , .
.
. , ,
.
.
,
,
. , ,
.
, .
.
.
, .
.
90 % , 92 %
, .
Poland ,
.
7.
1.4
, , .
.
, 16 23 mm.
,
.
. .
, .
,
( 5).
.
.
.
,
. .
1.
2.
3.
4.
5.
6.
5 :
.
. , -
15
. , . ,
. 5.
. .
1.
2.
3.
4.
5.
1.5 A
16
,
.
.
,
.
.
. , 2/3 1/3
.
().
.
.
,
.
.
, , .
6-8 , |
6: .
, . .
.
. ,
, .
. ,
,
. , ,
,
. ,
.
: , , ,
. 3 : ( ), ( ) ( ).
.
, . , -
.
.
, .
b
.
,
.
. . , ( )
( ).
. ,
.
.
.
.
, 1 - 3,
.
.
7: . (: Counselling
the nursing mother: A lactation consultants guide (5th ed). Sudbury,
MA: Jones & Bartlett Learning).
A () ()
8: .
17
. 3-4
. 1/3
.
:
( , , , ).
.
.
.
.
.
.
,
, .
, ,
.
18
I -
, .
V ( )
VII (
)
, , ,
.
2/3
.
, .
( )
1/3 ( ), , .
-
( )
, ,
.
.
.
1:
,
. . 2 4 .
: 32 . , .
. 40 3 .
: .
, .
15 24
|
. 3
.
:
12 . . ,
,
28 37 .
: 26
.
:
.
1.
2.
3.
4.
5.
6.
7.
19
,
. ,
, ,
-
.
2.1
, .
,
.
.
.
.
: ( ), ( ) ( ). ( 9).
,
.
,
.
1.
. .
o .
:
,
.
ACTH: , EGF:
, GH: , IGF-1:
-1, PRL: .
, -
( )
( )
( )
9:
, ,
.
1 .
, ,
(). , , , , - ,
,
,
.
.
,
.
, -
21
.
, , : ,
.
. . 10
.
L I
L I
LI
,
. ( ).
,
,
.
36-96 , . .
(demand feeding),
.
, .
L I: , 16-22
L I: , 30-40
L I: , >72
22
10: : .
. . ,
.
, .
,
. T
. ,
,
. . (IGF) , .
IGFs.
10.
11: ()
().
,
, (),
, ,
(). , ,
(1- 4 ),
(4 -14 )
(>14 ) (K 4). 12.
, ,
,
4 ,
30-40 . |
10
11
12
13
14
15
16
17
12:
1- 17
, .
3 ,
.
. , .
,
. , ,
30-45 .
75 7-20 , ,
.
,
. , .
.
, ,
, . ,
.
,
.
(Feedback Inhibitor of Lactation-FIL), , . FIL
.
. , ,
. , .
( 150 ng/ml),
50 ng/ml 6 10-20 ng/ml. . ,
. , .
,
:
- .. , .
..
- .. .
,
,
.
.
&
13:
.
1.
2.
3.
4.
5.
6.
Cregan MD, Mitoulas LR, Hartmann PE. Milk prolactin, feed volume
and duration between feeds in women breastfeeding their full-term
infants over a 24 h period. Exp Physiol. 2002 Mar; 87(2):207-14.
Hale T, Hartmann P. Textbook of Human Lactation. 1st ed. Texas USA:
Hale Publishing; 2007.
Hovey RC, Trott JF, Vonderhaar BK. Establishing a framework for the
functional mammary gland: from endocrinology to morphology. J
Mammary Gland Biol Neoplasia. 2002 Jan; 7(1):17-38.
Hurst NM. Recognizing and treating delayed or failed lactogenesis II. J
Midwifery Womens Health. 2007 Nov-Dec; 52(6):588-94.
Jones E, Spencer SA. The physiology of Lactation. Paediatr Child
Health. 2007 Jun; 17(6): 244-248.
Kulski JK, Hartmann PE. Milk insulin, GH and TSH: relationship to
changes in milk lactose, glucose and protein during lactogenesis in
women. Endocrinol Exp.1983 Oct; 17(3-4):317-26. (bstract)
23
7.
8.
9.
10.
11.
12.
13.
14.
15.
2.2
,
24
, ,
, . 28 37
.
, .
.
,
. ,
,
.
. ,
. ,
.
.
,
,
.
3-5 .
.
. (pads)
.
.
,
.
, :
,
, .
.
, ,
. ,
.
, , . ,
. ,
. , ,
, , .
. (MER: milk ejection reflex
let-down reflex). , , .
- .
4 .
.
, ,
.
posterior
pituatory gland
nerve
pathways
oxytocin
in blood
milk ejection
14:
(MER: milk ejection reflex let-down reflex).
1.
2.
3.
4.
5.
6.
.
.
6 (FSH) (LH)
,
. LH
,
GnRH,
.
O
(Lactational Amenorrhea Method-LAM),
3 :
6
56 .
.
, ,
. , /, tandem nursing , .
1.
2.
, ,
3.
4.
25
3
. , ,
, .
1 4 .
, , ( ), , ,
(Epidermal growth factor-EGF) , ,
. ,
. 2
- .
(1 )
(cal /lt)
57
65
(gr/lt|)
20
35
(gr/lt)
32
(gr/lt)
12
29
2:
(1 )
,
.
. 3
.
IgG
IgM
IgA
80
120
11.000
50
40
2.000
25
10
1.000
8-50
10
10
1.000
3: H
(mg/24 h) .
Remington JS & Klein JO (2001) Infectious Diseases of the Fetus
and Newborn, Fifth Edition. Philadelphia, WBSaundersCo.
. 4 .
24
37 (7-123 ml)
-5ml
7ml
84(44-335ml)
5-15ml
13ml
408ml
(98-775ml)
15-30ml
27ml
705ml
(452-876ml)
30-135ml
57ml
4: ,
4 .
4 14 .
2 (48-72 )
, .
.
, /
.
To
14 . 600-900ml ( ). O
.
N: 87 % ,
.
27
: -3 , (DHA)
(Long Chain Fatty Acids LCFA), .
,
, foremilk , hindmilk.
50 % .
: , , / 3:2,
-
.
, , 6 . (<28 )
, . ,
.
28
(Epidermal Growth
Factor-EGF), ,
. EGF . EGF
. ,
,
EGF, ,
.
. , 7,2 %.
,
bifidus.
Lactobacillus bifidus,
. bifidus
.
. O
. ,
( 5). , ,
, . .
49 %
4%
10 %
5: H
.
.
D ,
. , 400IU D, 6 .
, , .
, ,
D .
,
,
. 0,5mg 2mg , 2mg 2mg 4 .
K .
, , .
IgA. Ig , .
IgA ,
. ,
,
, --
(entero-broncho-mammary pathway).
. . . ,
bifido . bifido , .
Transforming Growth Factor (GF ) . -
.
, , , (.. , , )
. , TGF-,
IL-10, 1L-13
.
.
, ,
, . , , IGF-1,
.
(<1500)
, ,
, (Human milk fortifier, HMF).
, , .
T
6
6 .
, ,
.
6.
, ,
, , . . , .
, , - . .
( PROBIT) , ,
, .
4,3 %,
(Collaborative Group on Hormonal Factors in Breast Cancer,
2002). , ,
,
28 %
(Ip S. et al, 2009). ,
1 2 .
(Lactational
Amenorrhea Method)
6 :
.
29
30
,
.
,
. ..
..
, .
. , Cronobacter sakazakii Enterobacter sakazakii,
Salmonella enterica, Clostridium botulinum,
. , .
UNICEF WHO
.
, ,
, , ..
, , .
,
.
. , .
,
.
2008 300.000
.
, 6 .
, .
, ,
.
. IgA ,
,
.
. ,
. ,
, ,
.
.
Th1 ,
|
Th2 . .
,
Th2 .
( )
2.
1, - .
, .
.
,
.
. , ,
.
.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10. Gartner LM, Morton J, Lawrence RA, Naylor AJ, OHare D, Schanler
RJ, Eidelman AI; American Academy of Pediatrics Section on
Breastfeeding. Breastfeeding and the use of human milk. Pediatrics.
2005 Feb; 115(2):496-506.
31
4
4.1
H
. A
.
() UNICEF 3:
.
, 16 %
.
4 . ,
.
Academy of Breastfeeding Medicine
, :
/ .
.
,
.
,
.
, . ,
, -
(
). ,
,
- /
.
. , ,
.
,
.
,
. ,
.
.
, . ,
.
,
.
1.
2.
3.
4.
5.
33
6.
3.
4.
4.2
5.
34
. ,
,
(, , ).
.
o . , - .
, ,
. :
. ,
. ,
.
.
UNICEF, , .
,
.
, . ,
.
,
.
.
1.
2.
6.
7.
8.
9.
4.3
24
24. () UNICEF
7 .
,
.
,
.
, ,
,
5 %, ,
,
. , 3 5
.
. ,
,
.
, .
,
,
,
. ,
- .
, ,
, .
.
1.
2.
3.
4.
5.
6.
7.
8.
4.4
15: .
, ,
, .
, ,
(rooting reflex).
.
35
:
1. .
2.
.
( ).
3. ,
.
4. .
5.
. , .
6. ,
. ,
,
.
.
To
36
16:
.
4.5
.
.
:
.
.
, , .
.
, .
|
,
.
,
. ,
.
,
, ( C). .
.
C
.
.
(Side-lying hold )
, ,
.
(Cradle hold)
.
.
(Rugby ball)
17: C.
.
.
Rugby
18: .
Hand Expression, The Womanly Art of Breastfeeding, LLLI 2010, Tear-Sheet Toolkit/06
La Leche League International Tear-Sheet Toolkit The Womanly Art of Breastfeeding, 8 , 20,
La Leche League International http://www.llli.org/toolkit Copyright (c) 2010, La Leche League International.
37
, ,
.
.
,
rugby.
1.
2.
3.
38
4.6
8 UNICEF, .
.
,
, .
,
, .
,
,
. ,
. Anderson GC (1989),
, ,
, , ..
: ,
.
,
.
,
. ,
,
,
.
2-3 8- 12 .
. , -
( , ,
) .
1.
2.
3.
4.
5.
6.
7.
8.
9.
4.7
, , , ,
.
IBFAT
MBA
LATCH
SAIB
LAT
MIBPT
7:
,
, , ,
.
UNICEF .. , ,
, ( ) , .
.
, , , ,
, (, ), , .
, .
(3- 5 )
( 8).
39
: 4
4 24
: 4
4 24
:
.
:
8-12/24
:
5-40
8: E
40
. 3 24
7 %.
. , . .
,
, 15 .
.
. ( ).
, 4- 5 4 , , ,
.
5
. 4-6
.
, , .
, 24
. 2-3 24 . 6 .
, .
,
.. |
.
,
8-12 , , .
, . 2006.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
4.8
, ,
. , -
. , ,
.
,
, .
4 /
1
1 100 %
1
3-4 /
1
1 100 %
(, , ..)
6-8 /
1
1
,
3 /
1 225.
40 .
55 .
( / )
2-3 /
120-150 . ,
,
4-5 /
2-3 /
180-250 .
>3 /
1 ,
/,
,
4-5 /
9: .
: , , 2014.
41
.
. ,
13 9,
.
.. , , 200 mg .
M .
67 100/.
780 . /
780*67/100= 522 .
/24
42
780ml/
67 Kcal/100ml
522 Kcal/
10
: , .
,
( ).
, ,
, , , . , .
1000mg
.
.
.
|
: , , , , .
,
. ,
. ,
, ,
12.
D
,
D.
D.
D .
:
, , , , , , - - . ,
, .
.
(
) . ,
.
.
:
,
25 . .
3 : -3
.
.. , ,
-
.. , .
, .
45
500kcal/
-
. 2
.
200-300 .
,
. . ,
.
1.
2.
3.
4.
5.
6.
4.9
, , ,
.
.
,
.
. , ,
.
(2014)
.
,
,
.
1.
2.
3.
4.
5.
43
5
.
. ,
.
. ,
. 2/3
.
,
.
5.1
:
.
, , .
.
.
, 72 . .
.
. , .
Feedback nhibitor
of Lactation (FIL), .
FIL
,
. ,
.
:
1. .
2. ..
.
3. .
4. .
5. .
6. , .
7. .
.
50 72 , 7
:
,
38,5oC
,
,
.
. Cotterman (2004) . . ,
,
.
.
, :
.
.
, .
45
. Snowden (2001),
.
,
.
, ,
.
,
,
. . ,
.
1.
2.
3.
4.
5.
6.
7.
8.
5.2
6 . ,
.
.
( )
46
Paget
Raynaud
()
()
(Staph areus)
(..
)
(Staphylococcus
aureus)
11: .
|
5.2.1
. , , , , , , .
, , .
. ,
, .
.
,
.
,
.
.
.
, , .
, :
1. .
2. . ,
.
3. ,
.
4.
.
5.
, ( 17)
5.2.2
.. , , ,
.
5.2.3
, .
,
.
. , , .
:
, .
() , .
Hoffman: A
, ,
.
. ,
. 1-2 .
.
20: Hoffman
( ).
,
. , ,
.
,
, .
,
:
C U .
47
(Tea cup hold).
1.
2.
3.
5.2.4
48
Candida lbicans
, . : ,
, . , , ,
, , .
.
.
,
, .
.
.
. .
.
.
, .
. ,
, ,
.
/ .
, .
.
.
. , ..
, , , , , , .
, .
.
, . ,
, -
. .
. . , , .
22: .
,
.
.
, , .
.
.
.
,
. , , .
. , .
(Bleb)
.
.
,
, .
. . .
23: ( bleb).
49
(Blister)
. .
, . .
,
. , , ,
.
Raynaud ,
, ,
.
.
- D-MER (Dysphoric
Milk Ejection Reflex)
D-MER..
3-7 .
.
. ,
.
( 30
).
. ,
.
50
Paget
24.
.
. .
. ,
,
.
. , , , .
.
, .
1.
Raynaud
T
, ,
, . Raynaud
,
, ,
, ..
|
2.
3.
4.
5.
6.
7.
8.
9.
5.3
.
, .
, ,
.
,
.
. :
,
.
38,5 C.
.
.
.
.
. .
. ,
, ,
.
24-48 .
.
1.
2.
9,5 %
. .
, .
. (MRSA),
.
, . ,
, ,
, ,
, .
:
, , , .
.
38,5 C.
, ,
.
. ,
.
,
.
, .
.
,
. ,
. ,
.
. .
. , ,
.
51
52
12-24
. .
.
,
24. ,
.
. , . .
, .
, . , , ,
,
,
.
: ,
.
.
, .
,
.
, ,
. > 5 .. ,
5-7 .
, , ,
.
.
1.
2.
3.
25:
. 3 %
.
.
Staphylococcus aureus
Coagulase-negative Staphylococcus (CONS). , (MRSA). ,
|
1.
2.
3.
4.
5.
5.4
.
( ),
.
1938 British Medical Journal
Spence : 5 % ,
.
. 5 %
.
.
.
. , .
. , ,
. .
, .
,
, (, , ) Sheehan ( , ).
,
, .
.
.
.
,
.
,
. ,
.
72 .
:
.
.
.
.
.
.
, ,
,
.
- ,
.
.
4 . 1
4
. 34
. , 12
. ,
2 3 ,
4.
, . , , .
:
1. .
2.
, ,
53
.
3. .
4.
Supplementary Nutritional System (SNS), -
.
5. , .
.
, .
54
.
,
, . , , .
:
-
.
,
.
.
. ,
(.. ,
, , /
) .
,
( , , , , ).
.
, .
( )
().
12. ,
, .
(2011) :
, .
, .
.
Cilroton
Primperan
(Fenugreek)
(Silymarin)
10mg
3/
10mg
3-4 /
3 /3-4
(580-610mg)
1
3/ (1/4
240ml
10 )
420 mg/
1
2-3 /
(1.. 240ml
10
)
14
14
.
63 .
, , ,
QTc
,
.
...,
, ,
,
,
,
,
,
, , , .
, ,
, , , ,
Asteraceae/
Compositae (.. ).
12:
/
, .
.
. .
.
,
.
, ,
( , , ).
/ , . .
, ,
. , 2-3 , 1-2
, .
/
.
.
.
,
. . / ,
. ,
,
.
, , 3-4 , , C U.
. .
, .
,
. ,
. ,
.
55
( 26)
56
,
.
37C ( ).
To
(bain-marie) .
.
24 .
.
. ,
.
,
.
, 1-2 .
,
.
, ,
. , ,
.
60, 80 100 ml.
, .
(16-29C)
(15 C)
(0 4C)
(-4 -20C)
3-4
24 **
2-4
3
6
24
*
**
13: O
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
5.5
.
. , , .
, , , , , , .
. .
. ,
, . ,
.
.
,
.
,
. 60mg
. , 4-7 . ,
, , , . 3
.
1.
57
5.6
. ,
. , . , ,
.
.
. ,
- -
,
.
. , 850.000 .
,
(FDA 2011).
4 8
.
,
.
58
27:
,
.
3.
4.
5.
1.
2.
Center for Devices and Radiological Health U.S. Food and Drug
Administration. FDA Update on the Safety of Silicone Gel-Filled
Breast Implants [Internet]. 2011 Jun. : http://www.fda.
gov/downloads/medicaldevices/productsandmedicalprocedures/
implantsandprosthetics/breastimplants/UCM260090.pdf
Hill PD, Wilhelm PA, Aldag JC, Chatterton RT. Breast augmentation and
lactation outcome: a case report. MCN Am J Matern Child Nurs. JulAug 2004; 29(4): 238-42.
6.
7.
59
6
, .
6.1
12 .
,
.
.
C
C
.
.
,
C . , ,
,
.
(AIDS)
. ,
.
HIV , 3
.
,
, , . (
) .
6
. ,
(ZDV), (3TC) , ,
.
H
- (Varicella-Zoster Virus,
VZV).
. .
, 1021 . 2
(6-8 ). .
95 % .
-
.
, , , .
2
, (
48-72 92 )
(VZIG). , .
.
, , .
. , .
61
.
.
.
,
.
.
.
, .
.
.
() 6 . BCG ,
.
,
BCG.
INH 6 .
, , .
, .
(
6)
HIV.
(CMV)
62
. . , .
,
, .
,
.
, .
50-60 %
CMV.
,
. ,
.
< 1500 <32 ,
. 15 % 25 %
, , (,
, , , ,
, ).
.
10 14 .
.
Holder ( 62.5C 30 )
, (72C 5-10 ) CMV
, .
CMV .
|
1.
2.
3.
4.
5.
6.
7.
8.
9.
10. Lanzieri TM, Dollard SC, Josephson CD, Schmid DS, Bialek SR. Breast
milk-acquired cytomegalovirus infection and disease in VLBW and
premature infants. Pediatrics. 2013 Jun;131(6):e1937-45.
11. Lawrence R.M., Lawrence R.A. Breast milk and infection. Clin Perinatol.
2004 Sep; 31(3):501-28.
12. Mast EE. Mother-to-infant hepatitis C virus transmission and
breastfeeding. Adv Exp Med Biol. 2004;554: 211-6.
13. Previsani N, Lavanchy D. Hepatitis B. [Internet]. [Geneva]: World Health
Organization; 2009. : http://www.who.int/csr/disease/
hepatitis/HepatitisB_whocdscsrlyo2002_2.pdf.
14. Read JS; American Academy of Pediatrics Committee on Pediatric
Aids. Human milk, breastfeeding, and transmission of human
immunodeficiency virus type 1 in the United States. Pediatrics. 2003
Nov;112(5):1196-205.
15. Revello MG, Gerna G. Diagnosis and management of human
cytomegalovirus infection in the mother, fetus, and newborn infant.
Clin Microbiol Rev. 2002 Oct;15(4):680-715.
16. Sendelbach DM, Sanchez PJ.Varicella, influenza: not necessary to
separatemother and infant. Pediatrics. 2012 Aug;130(2):e464; author
reply 465-6.
17. Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, Moffat C,
Makhema J, Moyo S, Thior I, McIntosh K, van Widenfelt E, Leidner J,
Powis K, Asmelash A, Tumbare E, Zwerski S, Sharma U, Handelsman
E, Mburu K, Jayeoba O, Moko E, Souda S, Lubega E, Akhtar M, Wester
C, Tuomola R, Snowden W, Martinez-Tristani M, Mazhani L, Essex M.
Antiretroviral regimens in pregnancy and breast-feeding in Botswana.
N Engl J Med. 2010 Jun 17;362(24):2282-94.
18. Stehel EK, Sanchez PJ. Cytomegalovirus Infection in the Fetus and
Neonate. NeoReviews. Jan 2005; 6 (1); p. e38 -e45.
19. Walker. World Health Organisation. Prevention of HIV in infants and
young children. Lancet. 2002 Jul; 360 (9329):284-9.
20. World Health Organization. Guidelines on HIV and Infant Feeding 2010.
Principles and recommendations for infant feeding in the context of HIV
and a summary of evidence [Internet]. 2010. : http://www.
who.int/maternal_child_adolescent/documents/9789241599535/en/
21. World Health Organization Statement: Breastfeeding and maternal
tuberculosis. [Internet]. 1998. : http://www.who.int/
maternal_child_adolescent/documents/pdfs/breastfeeding_and_
maternal_tb.pdf
3.
4.
5.
6.2
.
6.
()
. , , 1 . ,
.
,
:
1.
.
2.
7.
. To ,
. ,
,
. ,
24-72 .
, , .
.
, ,
, .
.
, ,
. , .
,
.
. ,
. 24
, . ,
50 % .
.
, .
. ,
,
.
, , I, II. ,
,
,
63
, .
,
.
1.
2.
3.
4.
5.
6.
7.
8.
64
9.
10.
11.
12.
13.
.
, .
. , ,
. ,
, ,
.
|
,
,
.
.
. .
90 % .
1 %
, .
2 .
1.
2.
3.
4.
5.
. . ,
.
T4 T3 .
.
, . , .
.
.
. ,
.
, (<300 mg/
20-30 mg/ ),
, .
, . ,
.
4
.
,
. 7 % (
). 1, .
2-6
, 3 . 1/3
. , . .
3-12
, 8 ,
20 % -64 % . , ,
, , ,
, . , ,
.
1.
2.
3.
4.
5.
6.
.
33,7 %.
().
.
,
.
,
, .
,
:
()
( )
. . , ,
, , .
, ,
, , .
. ,
,
.
5- ,
. , ,
,
.
leflunomide
.
65
. ,
.
.
. ,
, .
1.
2.
3.
. , . , . , . , . , . , . , . , . , . , . , . , . , . , . , . , ., . .
: . ESORDIG. . 2003;84:18-206.
Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS.
Hormonal and reproductive risk factors for development of systemic
lupus erythematosus: results of a population-based, case-control
study. Arthritis Rheum. 2002 Jul;46(7):1830-9.
stensen M, Motta M. Therapy insight: the use of antirheumatic drugs
during nursing. Nat Clin Pract Rheumatol. 2007 Jul;3(7):400-6.
66
.
.
,
.
, ,
.
, , .
:
.
, .
,
.
, ,
.
. , ,
, ,
, -
.
, ,
, .
.
.
4-8
, ,
.
1.
2.
6.3
. .
( ).
- (HTLV ype I & ).
, HIV .
.
- ( , , 2 ).
( , ).
5 2 (
, ).
.
(
).
( L5 Hale).
.
C .
.
(CMV) .
/ .
. .
, , ,
,
.
HIV .
CMV. . .
14. .
1.
2.
3.
4.
5.
6.
Hale TW. Medications and Mothers Milk. 11th ed. Amarillo, Texas, USA:
Pharmasoft Publishing L.P; 2004.
Huner G, Baykal T, Demirkol M. Breastfeeding experience in inborn
errors of metabolism other than phenylketonuria. J Inherit Metab
Dis.2005;28(4):457-65.
Lawrence RM, Lawrence RA. Breast milk and infection. Clin Perinatol.
2004 Sep;31(3):501-28.
67
7.1
60 % 80 %
,
6 mg/dL.
,
. , 25 mg/dl
,
.
, 24 , 3-5 .
, , <5 mg/dL 15 mg/dL. -
15 mg/dl (2 %)
(0,3 %).
2 4
.
. , , . , , , ( 15), .
( 28)
24
Coombs,
(. G6PD).
<38
, ,
, , ,
( 28)
( )
>41
72
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn
infant 35 or more weeks of gestation. Pediatrics. 2004 Jul;114(1):297-316.
15:
69
4-7
.
. 20-30 %
2-3
. .
. , (UGT1A1), Gilbert.
70
, .
.
(35-37 ),
.
,
8 12
,
,
.
.
10 %,
.
48
, ,
2 . , ,
, .
28 29,
95 /
.
. 16 .
, ,
.
. , .
. 3 g/dL.
()
- Coombs Coombs
.
Glucose-6-phosphate dehydrogenase (G6PD)
G6PD
.
G6PD . , .
screening TSH.
.
. ,
.
screening
screening .
16:
.
|
. 30 2 4 . , -
()
( 30), . , , ,
.
Bhutani et al. Pediatrics 1999;103:6-14
(mg/dL)
20
(1)
(2)
15
(3)
10
(4)
(1) 40% - 12
(2) 13% - 24
(3) 2% - 48
(4) 0% -
0
0
12
24
36
48
60
72
84
96
108
120
132
144
()
28 : .
(35 .)
(mg/dL)
20
15
10
( 38 . )
( 38 . 35-37 .
(35-37 . )
24
48
72
96
120
144
()
(): Rh, ABO G6PD, ,
, , ,
29: ( 35 )
(: :
35 ).
71
(35 .)
(mg/dL)
30
25
20
15
( 38 . )
( 38 . 35-37 .
(35-37 . )
10
24
48
72
96
120
144
()
(): Rh, ABO G6PD, ,
, , ,
30: ( 35 )
72
(: :
35 ).
, , .
,
.
48 , , . , , -
,
2-3mg/dl . , ,
. , . , ,
.
, 72
.
,
.
, 9 %
28 ,
.
( 20mg/dl). (
14 21
),
.
, ,
.
48
.
.
,
/ .
. . ,
/
, , , , .
, . , .
, .
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
73
7.2
.
. 15 mg/dL . ,
50 80 mg/dL
.
, ,
.
,
, , . ,
.
, ,
2 3 ,
,
-
74
. , , ,
. 2 3 ,
, ,
. , ,
.
, 48 72 , , 45 mg/dL. ,
.
,
( 17), . (
0-20mg/dl)
. , , .
, ,
,
17:
, .
.
( 18) , , . ,
,
. , -
, ,
.
24 .
, 48 ,
,
, .
, 2 4 .
: -,
-
(IUGR)
-
-
Rhesus
18:
.
75
76
,
.
. , .
, (2 mL/kg ,
10 % ), 6-8mg/kg/min
30- 60
4 . ,
rebound
.
, .
.
. ( 18),
, , , .
1.
2.
3.
4.
5.
6.
7.
8.
7.3
, .
,
. ,
.
,
.
.
:
:
, .
,
.
. ,
( , , ).
,
,
(let down reflex) .
: K . ,
, .
.
. ,
.
,
.
.
K 4.
/
.
. ,
.
, , .
.
, .
.
, . ,
.
.
, ,
, ,
.
1.
2.
3.
4.
5.
6.
7.
8.
77
7.4
:
- , .
, ,
19: .
78
1. ,
.
.
2.
.
3. (kangaroo care).
- .
4. ,
(let-down)
.
5. . ,
, , , SNS.
, ,
.
6. , , .
,
( human milk fortifiers).
|
(foremilk)
(hindmilk), .
7.
:
. ,
.
. ,
,
.
.
.
, .
, ,
.
.
.
, ,
,
. .
1.
2.
3.
4.
7.5
(
)
, ( ) .
. -
5.
( ). , ,
.
0,8-2,7 1000 .
, .
. ,
.
31:
(. ) ,
:
.
() .
. ,
rugby . , .
.
,
.
(),
,
.
.
, .
. ,
, .
79
80
.
,
, . . ,
.
T,
:
,
( ).
.
. ,
, ,
. , .
.
,
. ,
,
.
,
.
,
.
.
,
.
, . , ,
.
(9-12 ),
. .
1.
( )
.
T 1: O
(,
)
.
, ,
. .
T 2: O
2-4mm
.
T 3: O
,
.
T 4:
:
(6 %).
()
.
32:
.
,
.
1.
2.
3.
4.
81
7.6
82
. 1 10 ,
- N .
28 (1980-2008) ( 4,66 % 9,62 %). , 2008,
7,45 %
1,66 % 1991.
(),
, ,
.
,
, . ,
,
.
, (<1500.)
. , ,
.
, () UICEF, ()
, ,
. , , -
, ,
.
,
. .
-
24 .
, ,
.
|
,
, . , , ,
.
, , () (). ,
.
7 .
,
,
.
110 135 kcal () , .
.
. ,
,
. , .
34 ,
( ),
,
. , ,
(). (bolus)
.
, , 15-30 %.
. ,
,
, ,
. , ,
.
, . 15g/kgr/
10g/kgr/.
, .
, , .
,
,
. ,
. ,
,
.
. ,
. ,
.
, , ,
,
.
,
.
, .
,
, .
(uman
Milk Fortifiers) .
, , , , , , .
.
100ml/kg () .
.
.
, ,
.
A
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
83
84
14. Nyqvist KH, Hggkvist AP, Hansen MN, Kylberg E, Frandsen AL,
Maastrup R, Ezeonodo A, Hannula L, Koskinen K, Haiek LN. Expansion
of the ten steps to successful breastfeeding into neonatal intensive
care: expert group recommendations for three guiding principles. J
Hum Lact. 2012 Aug;28(3):289-96.
15. Premji S, Chessell L. Continuous nasogastric milk feeding versus
intermittent bolus milk feeding for premature infants less than 1500
grams. Cochrane DatabaseSyst Rev. 2003;(1):CD001819. [Abstract]
16. Rogers SP, Hicks PD, Hamzo M, Veit LE, Abrams SA. Continuous
feedings of fortified human milk lead to nutrient losses of fat, calcium
and phosphorous. Nutrients. 2010 Mar;2(3):230-40.
17. Roz JC, Darmaun D, Boquien CY, Flamant C, Picaud JC, Savagner C,
Claris O,Lapillonne A, Mitanchez D, Branger B, Simeoni U, Kaminski
M, Ancel PY. The apparent breastfeeding paradox in very preterm
infants: relationship between breast feeding, early weight gain and
neurodevelopment based on results from two cohorts, EPIPAGE and
LIFT. BMJ Open. 2012 Apr 5;2(2):e000834.
18. SIFT Investigators Group. Early enteral feeding strategies for very
preterm infants: current evidence from Cochrane reviews.Arch Dis
Child Fetal NeonatalEd. 2013 Nov;98(6):F470-2.
19. Singhal A, Cole TJ, Fewtrell M, Deanfield J, Lucas A. Is slower early
growth beneficial for long-term cardiovascular health? Circulation.
2004 Mar9;109(9):1108-13.
20. Sisk PM, Lovelady CA, Gruber KJ, Dillard RG, OShea TM. Human milk
consumption and full enteral feeding among infants who weigh </=
1250 grams. Pediatrics. 2008 Jun;121(6):e1528-33.
21. Tudehope D, Fewtrell M, Kashyap S, Udaeta E. Nutritional needs of
the micropreterm infant. J Pediatr. 2013 Mar;162(3 Suppl):S72-80.
22. Van Den Driessche M, Peeters K, Marien P, Ghoos Y, Devlieger H,
Veereman-Wauters G. Gastric emptying in formula-fed and breastfed infants measured with the 13C-octanoic acid breath test. J Pediatr
Gastroenterol Nutr. 1999 Jul;29(1):46-51.
23. Velaphi S. Nutritional requirements and parenteral nutrition in preterm
infants. SAJCN S Afr J Clin Nutr [Internet]. 2011; 24(3): S27-S31. : http://www.google.gr/url?sa=t&rct=j&q=&esrc=s&sour
ce=web&cd=1&ved=0CCAQFjAA&url=http %3A %2F %2Fwww.ajol.
info %2Findex.php %2Fsajcn %2Farticle %2FviewFile %2F69807 %2F57
890&ei=8poAVciYL4qvPKPbgVg&usg=AFQjCNGL_JXA6a6wnN_LMg
VxEsFFLQBVbA&bvm=bv.87920726,d.ZWU.
24. Wauben IP, Atkinson SA, Grad TL, Shah JK, Paes B. Moderate nutrient
supplementation of mothers milk for preterm infants supports
adequate bone mass and short-term growth: a randomized, controlled
trial. Am J Clin Nutr. 1998Mar;67(3):465-72.
25. Williams AF. Early enteral feeding of the preterm infant. Arch Dis Child
Fetal Neonatal Ed. 2000 Nov; 83(3):F219-20.
26. William W, Hay Jr. Strategies for Feeding the Preterm Infant.
Neonatology. 2008; 94(4): 245254.
27. Ziegler EE, Thureen PJ, Carlson SJ. Aggressive nutrition of the very low
birthweight infant. Clin Perinatol. 2002 Jun;29(2):22
7.7 -
(....)
....
, . ,
,
....
,
, .... (, ,
, ).
, , ,
, , . ,
,
- .
....,
( , Kangaroo
care, baby massage, ) , .
.
-
... :
.
.
, , , .
,
. .
.
. ,
. , -
. . ,
. .... 5.
,
. , /,
, . ,
....
kangaroo care.
,
(/ ), .
kangaroo care
. ,
, . ,
.
, .
-
, . - - .
.
.
.
,
. , , , ,
. . , -.
.
:
.
, 32-34
,
.
85
7.8
,
,
.
86
33: .
. ,
. ,
, , .
34: SNS.
87
5.
.
, .
. :
1.
2. ,
3.
.
6.
,
. ,
, .
12.
1.
88
2.
3.
4.
7.
8.
9.
10.
11.
13.
14.
15.
16.
17.
18.
Hill PD, Aldag JC. Milk volume on day 4 and income predictive of
lactation adequacy at 6 weeks of mothers of non nursing preterm
infants. J Perinat Neonatal Nurs. 2005 Jul-Sep; 19(3):273-82.
Hill PD, Aldag JC, Chatterton RT. Initiation and frequency of pumping
and milk production in mothers of non-nursing preterm infants. J Hum
Lact. 2001 Feb; 17(1):9-13.
Hunt F. The importance of kangaroo care on infant oxygen saturation
levels and bonding. J Neonatal Nurs. 2008; 14(2):47-51.
Jefferies AL; Canadian Paediatric Society, Fetus and Newborn
Committee. Kangaroo care for the preterm infant and family. Paediatr
Child Health. 2012 Mar 1; 17(3):141-3.
Jones E, Dimmock PW, Spencer SA. A randomised controlled trial to
compare methods of milk expression after preterm delivery. Arch Dis
Child Fetal Neonatal Ed. 2001 Sep; 85(2):F91-5.
Kearvell H, Grant J. Getting connected: How nurses can support
mother/infant attachment in the neonatal intensive care unit. Aust J
Adv Nurs. 2010 March May; 27(3):75-82.
Mathur NB, Dwarkadas AM, Sharma VK, Saha K, Jain N. Anti-infective
factors in preterm human colostrum. Acta Paediatr Scand. 1990
Nov;79(11):1039-44.
Meier PP, Brown LP, Hurst NM, Spatz DL, Engstrom JL, Borucki LC,
Krouse AM. Nipple shields for preterm infants: effect on milk transfer
and duration of breastfeeding. J Hum Lact. 2000 May;16(2):106-14;
quiz 129-31.
Meier PP, Patel AL, Bigger HR, Rossman B, Engstrom JL. Supporting
breastfeeding in the neonatal intensive care unit: Rush Mothers Milk
Club as a case study of evidence-based care. Pediatr Clin North Am.
2013 Feb;60(1):209-26.
Nyqvist KH. Early attainment of breastfeeding competence in very
preterm infants. Acta Paediatr. 2008 Jun; 97(6):776-81.
Obeidat HM, Bond EA, Callister LC. The Parental Experience of Having
an Infant in the Newborn Intensive Care Unit. J Perinat Educ. 2009
Summer; 18(3): 2329.
Oddy WH, Glenn K. Implementing the Baby Friendly Hospital Initiative:
the role of finger feeding. Breastfeed Rev. 2003 Mar; 11(1):5-10.
Pinelli J, Symington A. Non-nutritive sucking for promoting physiologic
stability and nutrition in preterm infants. Cochrane Database Syst Rev.
2005 Oct 19;(4):CD001071. [Abstract]
Sisk P, Quandt S, Parson N, Tucker J. Breast milk expression and
maintenance in mothers of very low birth weight infants: supports and
barriers. J Hum Lact. 2010 Nov;26(4):368-75.
....
.... ,
, , . ,
, .
, <34 <1800.,
,
(, , ) . (, , ,
).
.
, , 2 . ,
(ESPGHAN
Committee on Nutrition, 2006).
....
:
(, ,
, ).
,
.
( ml )
.
.
5
.
1.
.
, .
.
2. T
().
. ,
.
.
:
,
.
.
E ,
,
.
(.. , , , SNS
).
.
3. M .
.
: ,
.
,
.
, , 2-3 . ,
20-30 ,
.
89
H
, ( ). 80 kcal/100 ml.
,
.
,
,
.
:
2-3
.
.
/, ,
, .
1.
2.
D.
D 200 400 IU/
1500g,
400 IU/,
, .
90
.
. ,
.
,
. 2
mg/kg/ ( 40mg/)
2 6
6 12 , ,
.
8 .
.
.
.
,
. ESPAGHAN
400-1000 gRE/kg/ (
1300-3300IU/kg/).
.
50 %
,
(. 200 IU/ D 1mg/kg
).
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
34 37 .
, . . , , , ,
, , .
.
,
. ,
12-24
, , , .
, ,
. >3 %
24 > 7 % 3 .
( 4), . , , .
:
1.
.
2. 10 % .
.
3. .
4. ,
, ,
.
1.
2.
3.
4.
5.
6.
1 2 , ,
.
(< 20g/)
2-3 :
.
.
.
.
T,
( ), .
91
8
H . (
90 %)
. ,
.
,
.
.
, .
.
8.1
,
,
o .
(),
(V). (-V) .
20: ,
.
, ,
.. .
,
, . .
:
1. Cmax:
.
2. (t) :
93
. t,
. ,
t .
(. 2, 3).
. 10 , (.. )
.
. A
.
()
(<500 Da)
.
PKa (PKa: Ph
)
(pKa>7.2) , pH 7-7.2.
. .
.
94
21: .
,
.
,
.
(Glomerulal filtration Rate - GFR)
25 % GFR
. , , CYP450 (first pass clearance).
:
, , ,
.
O
.
|
Milk/Plasma Milk/Serum ratio:
(/P M/S). 1, . O
, .
(..)
, M/P,
.
.
100 xM/PxA
=
(Exposure Index %) (ml/kg/min)
= ,
.. 150ml/kg/day=0.1 ml/kg/min.
.
..
2-3 /. .
10 % .
(Relative Infant Dose): E
.
10 %,
.
T.W. Hale (2006)
5 (L1-5). 22
L1
,
. :
, , .
L2
,
.
.
L3
,
,
.
.
L4
. , (.. , ).
.
L5
,
.
. .
A, , , ,
, , , .
22 : T Hale.
95
8.2 8.3
.
,
.. .
<10 %.
.
.
, .
:
t.
(t)
.
.
.
.
96
, :
,
.
,
, ..
.
(Cmax).
(t),
t.
.
..
.
.
,
.
: E
.
,
.
.
.
:
A , , : ,
.
:
.
,
.
M ( ):
.
:
.
16 % ,
6 mg/kg/.
6 %
.
:
.
:
.
:
, ,
.
:
.
:
8mg .
.
: .
.
( ): 8
.
: To
.
80
, 5
.400 .
-
. .
,
. .
.
.
, . (SSRIs) .
, .
360
. (SSRI+
) 11 .
97
8.4
,
8.5 ,
.
9 (2 ).
. , .
. .
. .
. .
St Johns Wort ()
.
.
grapefruit.
.
.
. 2001, ,
60-90. ,
,
.
.
3 ,
,
.
,
2,5 ,
.
.
,
.
0,5. / .
2 .
.
.
,
(neonatal abstinence syndrome).
:
.
.
90 .
.
.
.
98
1.
.
.
-
,
2-5, <1 1.4-1.7 ng/g .
1.
2.
3.
.
.
,
IUS
(LAM), .
,
.
8.6
:
A .
.
(IUS).
.
.
.
(medroxyprogesterone),
.
. , . .
Cochrane
, ,
.
,
21
42
.
:
(IUD)
( )
1.
2.
3.
4.
5.
6.
8.7
,
. ,
. . , ,
.
. 20-30 %,
40 %.
, ,
.
, ,
.
,
.
1.
2.
Begg EJ, Duffall SP, Hackett PL, Ilett K. Studying Drugs in Human milk:
Time to unify the approach. Human Lact. 2002;18(4): 323-332.
Ito S, Lee A. Drug excretion into breast milk--overview. Adv Drug Deliv
Rev. 2003 Apr 29;55(5):617-27.
99
9
9.1 O
.
()
6
, 6 . ,
,
.
, 6
. ,
,
.
,
. .
,
.
9.2 0-6
.
(exclusive
breastfeeding) , , .
4 , 4-6
6 .
,
, .
,
.
.
,
,
400 U D .
D
.
D 600 IU,
.
D
.
4-6 . ,
, .
. , 1
6 .
101
(Kcal)
1200
1000
800
600
400
200
0
3-5
0-2
6-8
9-11
12-23
102
(mg/)
1.4
1.2
1
0.8
0.6
0.4
0.2
0
0-2
3-5
6-8
9-11
12-23
E 35,36: A
,
1mg/kg/
4 . 2mg/kg/
1 12 .
A
1.
, ,
.
,
,
. , 2007
(World Health Organisation-Child Growth Standards,
WHO-CGS). MGRS
(Multicentre Growth Reference Study), 1997-2003 6 (, , , , ...) . ,
12 .
, 2011, 125
WHOCGS.
WHO-CGS , .
75 % 5
WHO-CGS.
,
,
1.
2.
3.
9.3
.
1990
NCHS/WHO
. , (1976), (cross sectional studies), , ,
. ,
4.
5.
6.
7.
103
9.4
104
. 0,5 %.
,
EuroPrevall, ,
.
.
T 12-18 . ,
, .
,
.
1-2 2-4 ..
, .
. ,
. , .. , ,
, .
12 ,
.
.
1.
2.
3.
4.
9.5
(suckling),
(sucking) 6 . 6
.
.
,
.
.
E,
,
.
,
.
5
.
6 5 (umami) .. (SchwartzC , 2013).
,
.
,
,
. , 6
.
6
,
,
.
.
6-8 2-3
,
. M 9
12
1-2 ,
.
(responsive feeding)
.
.
,
,
.
.
(Baby led
weaning-BLW). H
.
,
.
,
.
.
,
.
( ),
. ,
, ,
,
. ,
.
, ( ),
3-7 .
, ,
8-10 ,
.
, .
.
, 9-11 ,
:
97 %
86 %
81 %
73 %
72 %
.
1.
2.
3.
4.
5.
6.
7.
8.
9.
Cameron SL, Heath AL, Taylor RW. How feasible is Baby-led Weaning
as an approach to infant feeding? A review of the evidence. Nutrients.
2012 Nov2;4(11):1575-609.
Caroli M, Mele RM, Tomaselli MA, Cammisa M, Longo F, Attolini E.
Complementary feeding patterns in Europe with a special focus on
Italy. Nutr Metab Cardiovasc Dis. 2012 Oct; 22(10):813-8.
, .
, . (2014). [Internet]. : http://www.
diatrofikoiodigoi.gr/files/PDF/KIDS_PRO.pdf
La Leche League International. Starting Solids. New Beginings. 2008;
25 (5): 36-38.
Naylor AJ and Morrow A. Developmental readiness of normal full term
infants to progress from exclusive breastfeeding to the introduction of
complementary foods. Reviews of the relevant literature concerning
infant immunologic, gastrointestinal, oral motor and maternal
reproductive and lactational development. [Internet]. Washington D.C.,
Academy for Educational Development [AED], Breastfeeding, LAM
and Related Complementary Feeding and Maternal Nutrition Program
[LINKAGES]; April 2001. p. 36. : http://www.linkagesproject.
org/media/publications/Technical %20Reports/devreadiness.pdf
Rapley G. Guidelines for implementing a baby-led approach to the
introduction of solid foods updated; 2008 Jun.Downloaded from
www.rapleyweaning.com.
Schwartz C, Chabanet C, Laval C, Issanchou S, Nicklaus S. Breastfeeding duration: influence on taste acceptance over the first year of
life. Br J Nutr. 2013 Mar 28;109(6):1154-61.
Schwartz C, Issanchou S, Nicklaus S. Developmental changes in the
acceptance of the five basic tastes in the first year of life. Br J Nutr.
2009 Nov;102(9):1375-85.
Unicef UK and The Baby Friendly Initiative. Start 4 life. Introducing solid
foods. A good start for Healthier life [Internet]. Produced by Williams
Lea for Public Health England; 2011. http://www.nhs.uk/start4life/
documents/pdfs/introducing_solid_foods.pdf
105
9.6
.
.
. .
( , ,
.
.
2-3 ,
, 1-2
1-2 .
, ,
.
1.
106
2.
3.
9.7
/ / , .
.
. ,
.
,
. ,
, . , ,
, .
. , , .
, .,
2-5
, .
,
,
. . .
, , ,
, ,
.
,
, .
,
.
.,
- 6 -
.
,
.
, ,
. . ,
,
, , , .
,
, ,
. ,
. , ,
!
:
.
1.
2.
3.
4.
5.
6.
107
10
10
,
.
.
-
. ,
- , , ,
,
.
.
, .
.
, , ,
.
,
.
.
, , Carl von Linnaeus1 - .
,
. ,
-
. , 1. Carl Linnaeus (1707-1778): , ,
, .
,
, - .
, . ,
. , ,
,
.
. ,
. , ,
- - ,
, . ,
, ,
.
- . 2
, .. , ,
. -- , ,
.
3 .
, .
4
2. . , -
.
3. Winnicott ,
.
4. , .
109
, . , .
,
.
,
.
.
. 5.
20
. , ,
, , .
,
.
110
6
, .
, . 7 (mothering the mother)
,
.
,
,
.
. .
.
, , 5.
.
6. , - . .
7.
.
, , , .
.
.. , .
..
, - . , . ,
.
.
, -
.
Klaus Kennell
8, . . H
Breast Crawl, ,
UNICEF, WHO WABA
.
Breast crawl
.. ,
, . Widstrom , ,
.
,
100 . , , ,
9, ,
. B. Jordan, , , .
.
, Klaus
. , ,
.
8. Breast Crawl
.
9.
, .
.
Attrill (2002)
. (Taking In Stage
Taking Hold Stage Letting Go Stage)
, ,
.
,
- ,
. , 3-6 ,
, .
, ,
. ,
, Winnicott
, .
,
, .
,
.
Bowlby,
. , ,
, . , ,
.
, Winnicott
(primary maternal preoccupation).
.
. , -
Winnicott- ,
.
.
(bonding)
(attachment) ( Bowlby),
.
,
.
, (holding)10
.
, .
11
, .
,
12 , .
.
, , . ..
, ,
, . ,
, . , .
.
, ,
,
13 .
,
. ,
, . O
-
.
.
,
, .
( ,
.), (, , ,
.), (, , , .),
.
( )
. , .
10. (holding) Winnicott. -.
11. , .
12. - Winnicott- ( ) .
13. Winnicott, : )
, ) ,) ,
.
111
112
, ,
. ,
,
14
.
(1994): ,
,
-15 ... , ,
, ,
.
.
, ,
.
,
.
.
,
, .
S. Lebovici (1960)
. , .
(2010)
.
.
.
, .
. (.. /-, , , .) 14. (introjection) .
,
. (.. , , )
.
15. -
. ,
.
.
,
. .
, .
.
, ,
. , ,
.
,
.
, . ,
.
,
. ,
,
,
.
, ,
.
. . , ,
.
,
.
1950
16
.
, 1946
Benjamin Spock (1903-1998) Baby
and Child Care
. 16. ,
( ) : , , . . .
.
A
(La folie ches les enfants)
.Paul Moreau de Tours (1844-1908), .
,
,
, o .
Freud
/ .
. , , .
Freud, 17 - -
.
,
. , 18
. , 6-18
Lacan,
. ,
Lacan
.
Melanie Klein
, . , Klein
, . 19. . Klein , () (). , . Bion,
. 17. :
--.
18. Freud, : --.
19.
. . , ,
, .
.
Melanie Klein Donald Winnicott
.
Winnicott
, . Winnicott ,
,
.
Spitz Mahler,
. ,
Spitz, - .
. ,
.
Margaret Mahler ,
. , -
, .
, .
, .
, -
,
. , , ,
.
,
, . ,
.
,
.
, 20 -
. ,
, Konrad Lorenz. 20. O , .
113
, . ,
,
.
,
,
. ,
,
.
114
,
. ,
. - - . , ,
. , ,
.
, , .
- ,
.
, ,
. , . .
,
. H -
, . .
21. ,
.
21.
.
.
, , ,
, .
22 :
,
,
.
, , ,
.
, -
.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
. . : ,
2012.
. : ; () 18.3.2013. www.protagon.gr.
Attrill B. The assumption of the maternal role: A developmental
process. Australian Journal of Midwifery, 2002, 15 (1):21-25.
Brazelton B. & Cramer Bertrand. . : , 2009.
. . & - . 2005, 7 (1): 9-14.
Brockington I. Motherhood and Mental Health. Oxford University Press,
1996.
Ciccone A., Gauthier Y., Golse B., Stern D. . : University studio press, 2012.
Dixon S., Stein M. (2006) Encounters with Children. USA: Mosby.
(2010). . , :.
Fraiberg S. (2008). The Magic Years. USA,Scribner.
Gerhardt S.(2004). Why Love Matters. New York: Routledge.
Golse et al (2012). . :University Studio Press.
Golse Bernard (2008) . : . .:.
Golse Bernard. La pulsion dattachment, La psychiatrie de lenfant
2004:1,471,p5-25.
Graham M. Nurturing Natures. New York: Psychology press, 2011.
Hamberger Lars and Nilsson Lennart (2004). . : .
Henderson A. Understanding the Breast Crawl. Nursing for Womens
Health, 2011, 15:4, 296-307.
Holmes J. O John Bowlby . : , 2009.
. . () 2012. http://www.uthsc.edu/pediatrics/neurosciences/
docs/Symp_AndrewPapanicolou_09_karavatos.pdf
Kitzinger S. . : susaeta, 2006.
Klaus M, Kenell J.,Klaus P. . : , 2004.
Klein M. . : , 2002.
- . . . : , 2011.
. . :
Gutenberg, 1994.
22.
, .
35. . . : , 1999.
36. Watson Genna C. Support Sucking Skills in Breastfeeding Infants.
Burlington: Jones & Bartlett Learning, 2013.
37. Winnicott D.W. .
: , 2003.
38. Winnicott D.W. . : , 2002.
39. Winnicott D.W. . : , 1995.
40. . . : , 2010.
41. www.breastcrawl.org.
42. http://en.wikipedia.org/wiki/Benjamin_Spock
115
................................................................................................................................. 7
.................................................................................................................................... 9
1. ...11
1.1 ...........................................................................11
...........................................................................11
..............................................................................................11
...........................................................................................11
..............................................................................................................12
1.2 ................................................................................................12
................................................................................................................12
..........................................................................................................................................13
............................................................................................................................13
.......................................................................................................................................13
...............................................................................................................................................13
.........................................................................................13
1.3 ..................................14
.........................................................................................................................................14
..........................................................................................................................................14
( )..............................................................14
, ...............................................15
...........................................................................................................................................15
1.4 ......................................................................................15
................................................................15
1.5 A ................................................................................16
........................................................16
.........................................................................18
.....................................18
........................................................................................................18
2. ..........................21
2.1 ...................................................................................................21
...................................................................................................................................21
................................................................................................................................21
..............................................................................................................................21
............................................................................................................................22
...........................................................................................23
........................................................23
.........................................................................................................................................23
2.2 ..................................................................................................24
, ........................24
..............................................................................24
.............................................................................25
3. ......27
...............................................................................................................................................27
............................................................................................................................27
To ..............................................................................................................27
..............................................................................................................................29
..............................30
4.
....33
4.1 ..................................................33
4.2 ........................................................................................................34
..........34
4.3 .......................................................................................34
4.4 ...............................................................35
4.5 ..........................................................................................................................36
.........................................................................................37
4.6
4.7
4.8
............................................................................................................................38
..................................................................39
.......................................................................................................41
...............................................................................................................42
.....42
- ..........................................................................42
4.9 ............................................................................................43
5. .................45
5.1 ..............................................................................................................45
....................................................................................................................................45
5.2 ............................................................................................................................46
..................................................................................................................47
..................................................47
.............................................................................47
......................................................................................................................48
5.3 ........................................................................51
........................................................................................51
............................................................................................................................................51
............................................................................................................................................52
5.4 ................................................................................................................53
...........................................................................................................53
......................................................................................................53
.........................................................53
.........................................................................54
/ .......................................................................55
..................................................................56
5.5 ..........................................................................................................57
5.6 ....58
....................................................................................................58
.....................................................................................................58
6. ...........................................61
6.1 .............................................................61
........................................................................................................................................61
C.........................................................................................................................................61
(AIDS)..........................................................61
..................................................................61
.................................................................................................................................62
(CMV)..........................................................................................................62
........................................................................................................................................62
6.2 ............................................................................................63
................................................................................................................63
...................................................................................................................64
............................................................................................................64
.........................................................................................................................64
.......................................................................................................................64
..............................................................................................65
....................................................................................................................65
...............................................................................................................................................66
6.3 .......................................................................................67
7.
.....................................................................................69
7.1 ..................69
...................................................70
....................................................................................................................................73
7.2 ............................................................................74
..................................................................................................76
7.3 ....................................................................76
..................................................................76
/......................................................................................77
7.4 ................................78
......................................................................................................78
7.5
.............................................................................................................................................79
( )............................79
....................................................................................................................................79
.................................................................................................................................79
( )..................................................................81
7.6 ..............................................................................82
- .....................82
...............................................................82
.........................................................................82
.................82
................83
7.7 -
(....)......................................................................................................................84
- ... :
...........................................................................................84
..................................................................................................................................85
- ...........................................................85
7.8 .............................................................86
.......................................................86
SNS (Supplementary Nutritional System).................................................87
..................................................88
....................................................................................................................................89
......................................89
..........................................................90
.......................90
...................................................................91
.......................................................................................................................97
...................................................................................................97
8.4 ,
................................................................................................................98
...............................................................................................98
8.5 ,
..................................................................................................................................98
8.6 ....................................................................99
...............................................................................................................99
.......................................................................................................99
8.7 ......................................99
9.
...........................................................................................................101
9.1 O .................................101
9.2 0-6 .................................................................101
................................................................................................................................101
9.3 .
...................................................................................................................103
9.4 ..............................................................104
9.5 ................................................................................................104
9.6 .
....................................................................................................................106
9.7 ................................................................................................................................106
10. ...............................109
8.
.............................................................93
8.1 ........................................................................93
..............................................................................93
........................................................................................93
...................................................................................................................................94
...........................................................................94
...............................94
.............................95
8.2 .................96
.................................................................................96
8.3
.....................................................................................................................................96
:....96
......................................................97
................................................................................................................97
.............................................................................................................................97
- ....................................................................................................97
117
www.europa.eu
www.ygeia-pronoia.gr
www.epanad.gov.gr
www.espa.gr